It has been recently demonstrated that a reduction in E-cadherin expression is related to tumor growth, differentiation, growth and metastasis, suggesting a possible role of E-cadherin in cancer progression (Samatov et al., 2013; Choupani et al., 2018). Here, CDH1 is linked to neoplasm.